Company Filing History:
Years Active: 2000
Title: Innovations of James Z Xing in Nucleotide Sequence Modifications
Introduction
James Z Xing is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of molecular biology, particularly in the detection and quantitation of modifications in nucleotide sequences. His work is essential for advancing cancer research and therapy.
Latest Patents
James Z Xing holds a patent titled "Methods for quantitating low level modifications of nucleotide sequences." This invention provides methods for the detection and quantitation of any modification of interest in nucleic acid sequences. The methods utilize nucleic acid sequence modification-specific molecules, fluorescently labeled proteins, capillary electrophoresis, and laser-induced fluorescence. These techniques are particularly useful for identifying exposure to carcinogens, conducting early risk assessments for cancer, and monitoring cancer therapy.
Career Highlights
James Z Xing is affiliated with the University of Alberta, where he continues to engage in innovative research. His work has garnered attention for its potential applications in cancer diagnostics and treatment.
Collaborations
James has collaborated with notable colleagues, including Xiao-Chun Le and Michael Weinfeld, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
James Z Xing's innovative methods for quantitating nucleotide sequence modifications represent a significant advancement in molecular biology. His contributions are vital for improving cancer detection and treatment strategies.